Dr. Reese has over 14 years of scientific research experience in the fields of cardiovascular and developmental biology. He has published numerous articles in leading scientific journals and most recently a paper titled "Negative regulation of vascular development at midline by the notochord" in Developmental Cell (2004). Dr. Reese has focused on diverse research topics including diabetes, cardiovascular, cancer and molecular diagnostics.

Dr. Reese is currently a consultant to the financial industry on topics related to biotechnology and healthcare. His work includes analysis of product pipelines of public equities and the scientific basis of technology platforms in private sector research firms. In addition, Dr. Reese is a biotechnology sell-side analyst with over 80 companies in his coverage space. He holds a PhD in the Biomedical Sciences from Vanderbilt University and a BS in Microbiology from Arizona State University where he was the recipient of numerous academic and professional honors.